Inactive Instrument

Press Releases Nabriva Therapeutics PLC - ADR Nasdaq

Equities

US62957M1045

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Nabriva Therapeutics : Failure to Satisfy Listing Rule - Form 8-K	23-07-24	PU
NABRIVA THERAPEUTICS PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-04-17	AQ
Nabriva Therapeutics : Material Agreement - Form 8-K	23-02-06	PU
NABRIVA THERAPEUTICS PLC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-02-06	AQ
NABRIVA THERAPEUTICS PLC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-01-20	AQ
Nabriva Therapeutics : Termination of Material Agreement - Form 8-K	23-01-09	PU
NABRIVA THERAPEUTICS PLC : Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits (form 8-K)	23-01-09	AQ
Nabriva Therapeutics Provides Corporate Update	23-01-09	AQ
Nabriva Therapeutics Provides Corporate Update	23-01-06	AQ
NABRIVA THERAPEUTICS PLC : Other Events (form 8-K)	22-11-28	AQ
Nabriva Therapeutics Announces Positive Topline Results from Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis	22-11-28	AQ
Nabriva Therapeutics Pivoting Strategic Focus Reports Third Quarter Financial Results and Provides Corporate Update	22-11-11	AQ
NABRIVA THERAPEUTICS PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-10	AQ
Nabriva Therapeutics Pivoting Strategic Focus Reports Third Quarter Financial Results and Provides Corporate Update	22-11-10	AQ
Nabriva Therapeutics to Report Third Quarter 2022 Financial Results and Recent Corporate Highlights on November 10 2022	22-11-08	AQ
Nabriva Therapeutics to Report Third Quarter 2022 Financial Results and Recent Corporate Highlights on November 10, 2022	22-11-07	AQ
NABRIVA THERAPEUTICS PLC : Other Events (form 8-K)	22-10-04	AQ
Nabriva Therapeutics : Modification to Rights of Security Holders - Form 8-K	22-09-16	PU
NABRIVA THERAPEUTICS PLC : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-09-16	AQ
Nabriva Therapeutics Announces Date of 1-for-25 Reverse Stock Split	22-09-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Nabriva Therapeutics PLC - ADR Nasdaq

Equities

US62957M1045

Press Releases

Filters